Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ C5347209!5347209!28293653     free     free     free       Med+Hypothesis+Discov+Innov+Ophthalmol 2016 ; 5 (3): 78-88 Nephropedia Template TP {{tp|p=28293653|t=2016. Topical Atropine in the Control of Myopia |pdf=|usr=}}{{28293653}} gab.com Text Topical Atropine in the Control of Myopia JO: Med Hypothesis Discov Innov Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=28293653 #FOAvip Atropine has been used for more than a century to arrest myopia progression. Compelling evidence of its protective effect has been reported in well-designed clinical studies, mainly performed during the last two decades. However, its exact mechanism of action has not been determined. Experimental findings have shown that the mechanism is not related to accommodation, as was thought for decades. A review of the published literature revealed a significant amount of evidence supporting its safety and efficacy at a concentration of 1.0%, and at lower concentrations (as low as 0.01%). Twit Text FOAVip Topical Atropine in the Control of Myopia ????Med Hypothesis Discov Innov Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=28293653 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28293653 #FOAvip English Wikipedia <ref>{{Cite pmid|28293653}}</ref> Topical Atropine in the Control of Myopia #MMPMID28293653 GALVIS V; TELLO A; PARRA MM; MERAYO-LLOVES J; LARREA J; JULIAN RODRIGUEZ C; CAMACHO PA Med Hypothesis Discov Innov Ophthalmol 2016[Aut]; 5 (3): 78-88 PMID28293653show ga Atropine has been used for more than a century to arrest myopia progression. Compelling evidence of its protective effect has been reported in well-designed clinical studies, mainly performed during the last two decades. However, its exact mechanism of action has not been determined. Experimental findings have shown that the mechanism is not related to accommodation, as was thought for decades. A review of the published literature revealed a significant amount of evidence supporting its safety and efficacy at a concentration of 1.0%, and at lower concentrations (as low as 0.01%). äTopical Atropine in the Control of Myopia (epmc).pdf DeepDyve Pubget Overpricing